Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Magazine Issues

September Issue of The Medicine Maker

In this issue, our cover features looks at the mRNA field – asking what lies ahead for mRNA post-pandemic, featuring contributions from CureVac, Sartorius, and more. We also speak with the Drugs for Neglected Diseases initiative to learn about a partnership that brought a new hep C treatment to Malaysia. In In My View, we cover advanced therapies, rapid-dissolve tablet technologies, and the pharma supply chain. We also sit down with Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA.

Download Issue Articles in this issue

Previous issues 2021